PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.12%
Revenue growth above 1.5x 6617.T's 14.66%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
83.86%
Gross profit growth above 1.5x 6617.T's 30.08%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
157.15%
EBIT growth similar to 6617.T's 163.96%. Walter Schloss might infer both firms share similar operational efficiencies.
156.65%
Operating income growth under 50% of 6617.T's 374.75%. Michael Burry would be concerned about deeper cost or sales issues.
103.24%
Net income growth at 50-75% of 6617.T's 206.29%. Martin Whitman would question fundamental disadvantages in expenses or demand.
103.25%
EPS growth at 50-75% of 6617.T's 206.23%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
103.25%
Diluted EPS growth at 50-75% of 6617.T's 206.23%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-0.00%
Share reduction while 6617.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 6617.T is at 0.02%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.00%
Negative 10Y revenue/share CAGR while 6617.T stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-25.53%
Negative 5Y CAGR while 6617.T stands at 6.15%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
10.49%
Positive 3Y CAGR while 6617.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
100.00%
OCF/share CAGR of 100.00% while 6617.T is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.17%
10Y net income/share CAGR of 100.17% while 6617.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
-96.98%
Negative 5Y net income/share CAGR while 6617.T is 31.32%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-91.65%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
36.28%
5Y equity/share CAGR above 1.5x 6617.T's 2.63%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
29.51%
3Y equity/share CAGR above 1.5x 6617.T's 3.02%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.18%
AR growth well above 6617.T's 2.15%. Michael Burry fears inflated revenue or higher default risk in the near future.
9.15%
Inventory growth well above 6617.T's 3.44%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
8.03%
Asset growth above 1.5x 6617.T's 3.33%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-3.51%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
16.11%
Debt shrinking faster vs. 6617.T's 57.39%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
7.37%
We expand SG&A while 6617.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.